Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion Surgery
| Status: | Completed |
|---|---|
| Conditions: | Post-Surgical Pain, Hospital, Orthopedic |
| Therapuetic Areas: | Musculoskeletal, Orthopedics / Podiatry, Other |
| Healthy: | No |
| Age Range: | 10 - 21 |
| Updated: | 7/20/2017 |
| Start Date: | November 2011 |
| End Date: | December 1, 2016 |
There will be two groups in this study: one group will be given the standard infusion of
naloxone, a drug which helps reduce side effects from opioids needed after surgery, and the
other group will receive a higher dose. The trial is designed to determine if a higher dose
of naloxone infusion will reduce side effects from opioid therapy in patients who have
undergone spine fusion for scoliosis.
naloxone, a drug which helps reduce side effects from opioids needed after surgery, and the
other group will receive a higher dose. The trial is designed to determine if a higher dose
of naloxone infusion will reduce side effects from opioid therapy in patients who have
undergone spine fusion for scoliosis.
Currently, patients undergoing spinal fusion for scoliosis are routinely given patient
controlled analgesia (PCA) for pain control postoperatively. PCA therapy is typically
combined with an ultra low dose naloxone infusion because of the established benefit of
reduced pruritis and nausea. The investigators hypothesize that using a higher dose naloxone
infusion may lead to further improvement in pruritis and nausea and may improve GI function.
Improvement in bowel function could lead to faster initiation of oral intake as well as
transition to oral pain medication and even decreased length of stay.
controlled analgesia (PCA) for pain control postoperatively. PCA therapy is typically
combined with an ultra low dose naloxone infusion because of the established benefit of
reduced pruritis and nausea. The investigators hypothesize that using a higher dose naloxone
infusion may lead to further improvement in pruritis and nausea and may improve GI function.
Improvement in bowel function could lead to faster initiation of oral intake as well as
transition to oral pain medication and even decreased length of stay.
Inclusion Criteria:
- Idiopathic scoliosis requiring spine fusion surgery
- Age 10-21 years
Exclusion Criteria:
- Inability to understand PCA instructions
- Allergy to: morphine, hydromorphone, fentanyl, naloxone, or diphenhydramine
- Chronic opioid therapy > 2 months
- Non-English speaking
We found this trial at
1
site
Children's Mercy Hospital Children's Mercy Hospitals and Clinics continues redefining pediatric medicine throughout the Midwest...
Click here to add this to my saved trials
